Home Vital Sentences Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Free PDFs:
Hepatology 2014 (5th Edition, 612 pages)
Short Guide to Hepatitis C (2014 Edition, 206 pages)

Free Abstracts

  Malignant Melanoma

  Free Subscription


10.11.2014

1 Ann Surg Oncol
1 Anticancer Res
1 Biochem Biophys Res Commun
1 Clin Cancer Res
1 Cutis
1 J Biol Chem
1 J Invest Dermatol
1 JAMA
2 Melanoma Res
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. HASSAN S, Petrella TM, Zhang T, Kamel-Reid S, et al
    Pathologic Complete Response to Intralesional Interleukin-2 Therapy Associated with Improved Survival in Melanoma Patients with In-Transit Disease.
    Ann Surg Oncol. 2014.
    PubMed     Text format     Related articles    Abstract available


    Anticancer Res

  2. HAU HM, Tautenhahn HM, Schoenberg MB, Atanasov G, et al
    Liver resection in multimodal concepts improves survival of metastatic melanoma: a single-centre case-matched control study.
    Anticancer Res. 2014;34:6633-9.
    PubMed     Text format     Related articles    Abstract available


    Biochem Biophys Res Commun

  3. LEE K, Agrawal V, Kim K, Kim J, et al
    Combined effect of vascular-leakage-blocker Sac-1004 and antiangiogenic drug sunitinib on tumor angiogenesis.
    Biochem Biophys Res Commun. 2014;450:1320-6.
    PubMed     Text format     Related articles    Abstract available


    Clin Cancer Res

  4. CARLINO MS, Fung C, Shahheydari H, Todd JR, et al
    Pre-existing MEK1P124 mutations diminish response to BRAF inhibitors in metastatic melanoma patients.
    Clin Cancer Res. 2014 Nov 4. pii: clincanres.0759.2014.
    PubMed     Text format     Related articles    Abstract available


    Cutis

  5. YANG A, Klapman M, Cassarino DS
    Spontaneously regressing primary nodular melanoma of the glans penis.
    Cutis. 2014;94:E9-E11.
    PubMed     Text format     Related articles   


    J Biol Chem

  6. ZHAO B, Shah P, Budanov A, Qiang L, et al
    Sestrin2 positively regulates AKT signaling and survival in human squamous cell carcinoma and melanoma cells.
    J Biol Chem. 2014 Nov 6. pii: jbc.M114.595397.
    PubMed     Text format     Related articles    Abstract available


    J Invest Dermatol

  7. SHEEN YS, Liao YH, Lin MH, Chu CY, et al
    IMP-3 Promotes Migration and Invasion of Melanoma Cells by Modulating the Expression of HMGA2 and Predicts Poor Prognosis in Melanoma.
    J Invest Dermatol. 2014 Nov 7. doi: 10.1038/jid.2014.
    PubMed     Text format     Related articles    Abstract available


    JAMA

  8. HODI FS, Lee S, McDermott DF, Rao UN, et al
    Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial.
    JAMA. 2014;312:1744-53.
    PubMed     Text format     Related articles    Abstract available


    Melanoma Res

  9. ANFORTH RM, Carlos GR, Scolyer RA, Chou S, et al
    Eruptive naevi in a patient treated with LGX818 for BRAF mutant metastatic melanoma.
    Melanoma Res. 2014.
    PubMed     Text format     Related articles    Abstract available

  10. VULETIC AM, Jovanic IP, Jurisic VB, Milovanovic ZM, et al
    In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15.
    Melanoma Res. 2014.
    PubMed     Text format     Related articles    Abstract available


    PLoS One

  11. KRAMMER R, Heinzerling L
    Therapy Preferences in Melanoma Treatment - Willingness to Pay and Preference of Quality versus Length of Life of Patients, Physicians and Healthy Controls.
    PLoS One. 2014;9:e111237.
    PubMed     Text format     Related articles    Abstract available


    Proc Natl Acad Sci U S A

  12. GIORDANO M, Roncagalli R, Bourdely P, Chasson L, et al
    The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells.
    Proc Natl Acad Sci U S A. 2014;111:11115-20.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.

   Design: